Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Asia Sejahtera Mina Tbk (AGAR) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Asia Sejahtera Mina TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Asia Sejahtera Mina Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Asia Sejahtera Mina Tbk trades at Rp1,285 (market cap 1.03T, 3.31M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Asia Sejahtera Mina Tbk is the larger of the two by market cap, and Asia Sejahtera Mina Tbk is more actively traded (3.31M versus 843K). Which is the better fit depends on your goals.

AGARLABS
Market Cap
1.03T635.95B
Volume
3.31M843K
Lot
33.1K8.43K
Turnover
3.81B137.6M
Average Price
1,150.29163.22
Value
3.81B137.6M
Indicative Equilibrium Price
1,285165
Indicative Equilibrium Volume
2246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AGAR
View details
LABS
View details

About Asia Sejahtera Mina Tbk

PT Asia Sejahtera Mina Tbk (the Company) was established based on Notarial Deed No. 12 dated August 27, 2008 of Amelia Kasih, S.H., MKn. The parent company of the Company is PT Sinar Terang Asia Raya and the main parent entity is PT Indo Kreasi Pratama, both of which were established in Indonesia.

Read more on AGAR

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS